Skip to main content
Fig. 2 | Trials

Fig. 2

From: A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis

Fig. 2

Schedule of events. WK, week of treatment; MGIT, liquid media (BD mycobacterium growth indicator tube); LJ, Loewenstein - Jensen solid media; MBLA, molecular bacterial load assay; PK, pharmacokinetics; X, refers to all visits mentioned above; ZN, Ziehl-Neelsen stain; PG, pharmacogenomics

Back to article page

Trials

ISSN: 1745-6215